Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin-conjugating enzyme E2D 3 pseudogene
- Molecular classification
- Pseudogene
01
Overview
Ubiquitin-conjugating enzyme E2D 3 pseudogene (ENSG00000258901) is a genomic segment resembling the gene for ubiquitin-conjugating enzyme E2D 3 (UBE2D3) but does not encode a functional protein. It is classified as a pseudogene and is not considered a protein-coding gene, therapeutic target, or biomarker. Pseudogenes can appear similar to active genes due to gene duplication or other events, but they accumulate disabling mutations and lose their protein-coding capacity. This pseudogene may be transcribed at low levels in some tissues but does not serve any well-defined biological function, disease association, or role in drug targeting.
- Other names
- AL121821.3ENSG00000258901
02
Biological functions
No protein-coding or canonical biological functionMay possibly be transcribed at low levelsPseudogenes in general may have minor regulatory RNA roles, but these are specific to certain pseudogenes and not established for this one
03
Disease associations
None established for this specific pseudogeneSome pseudogenes play regulatory/disease-modifying roles but this is not described for ENSG00000258901
Beyond the preview
Go deeper on Ubiquitin-conjugating enzyme E2D 3 pseudogene.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ubiquitin-conjugating enzyme E2D 3 pseudogene.